Synopsis of recent research by authors named "Xiao-Li Zhu"
- Xiao-Li Zhu's recent research primarily focuses on the treatment and prognostic indicators of hepatocellular carcinoma (HCC), particularly emphasizing the impact of various therapies including transarterial chemoembolization (TACE), immune checkpoint inhibitors (ICIs), and anti-VEGF agents on patient outcomes.
- Key findings from multiple studies highlight the correlation between immune response indicators and tumor prognosis, such as the prognostic value of the CRAFITY score and the neutrophil-to-lymphocyte ratio in predicting survival rates in HCC patients undergoing different treatment approaches.
- Additionally, Zhu's work explores innovative therapeutic mechanisms, including the influence of transarterial embolization on PD-L1 expression and lymphocyte activity, indicating promising advancements in treatment strategies for advanced liver cancers and related conditions.
